Improved Stage Categorization of PTZ-Induced Kindling and Late Enhanced Neurogenesis in PTZ Kindled Mice.
Kindling
Neurogenesis
Pentylenetetrazole
Seizure Behavior
Subventricular Zone
Journal
Galen medical journal
ISSN: 2322-2379
Titre abrégé: Galen Med J
Pays: Iran
ID NLM: 101625418
Informations de publication
Date de publication:
2019
2019
Historique:
entrez:
1
9
2021
pubmed:
2
6
2019
medline:
2
6
2019
Statut:
epublish
Résumé
There is no universally accepted behavioral scoring to define the early development of pentylenetetrazole (PTZ) kindling. Therefore, studies investigating alterations of neurogenesis in the PTZ model were mainly focused on full kindled animals rather than early stages of kindling. This study aimed to determine an appropriate behavioral index for categorizing stages of PTZ kindling progress and to evaluate neurogenesis during PTZ kindling. Twenty-four mice were intraperitoneally injected with a sub-convulsive dose of PTZ (40mg/kg) every other day until they became full kindled. The first occurrence of different seizure behaviors and their durations were recorded during kindling development, and the different stages of kindling were categorized. Neurogenesis was evaluated in the lateral subventricular zone (SVZ) at each stage of kindling by immunofluorescence staining. First occurrence of restlessness, motionless staring, hind limb tonic extension, Straub's tail, myoclonic jerk, and tonic-clonic were sequentially observed in more than 80% of animals with increasing PTZ injections. The duration of the myoclonic jerk was significantly longer than the other seizure behaviors. The significantly higher percentage of BrdU-positive cells was found in SVZ of mice showing tonic-clonic in comparison to other seizure behaviors. A hierarchy behavior was observed during the kindling process when considering the first occurrence of seizure behaviors. We defined the first occurrence of restlessness, motionless, hind limb tonic extension and Straub's tail behaviors as an early phase, myoclonic jerk as a borderline phase and tonic-clonic as a late phase of PTZ-induced kindling. Our results indicated an enhanced SVZ neurogenesis at the late phase of kindling.
Sections du résumé
BACKGROUND
BACKGROUND
There is no universally accepted behavioral scoring to define the early development of pentylenetetrazole (PTZ) kindling. Therefore, studies investigating alterations of neurogenesis in the PTZ model were mainly focused on full kindled animals rather than early stages of kindling. This study aimed to determine an appropriate behavioral index for categorizing stages of PTZ kindling progress and to evaluate neurogenesis during PTZ kindling.
MATERIALS AND METHODS
METHODS
Twenty-four mice were intraperitoneally injected with a sub-convulsive dose of PTZ (40mg/kg) every other day until they became full kindled. The first occurrence of different seizure behaviors and their durations were recorded during kindling development, and the different stages of kindling were categorized. Neurogenesis was evaluated in the lateral subventricular zone (SVZ) at each stage of kindling by immunofluorescence staining.
RESULTS
RESULTS
First occurrence of restlessness, motionless staring, hind limb tonic extension, Straub's tail, myoclonic jerk, and tonic-clonic were sequentially observed in more than 80% of animals with increasing PTZ injections. The duration of the myoclonic jerk was significantly longer than the other seizure behaviors. The significantly higher percentage of BrdU-positive cells was found in SVZ of mice showing tonic-clonic in comparison to other seizure behaviors.
CONCLUSION
CONCLUSIONS
A hierarchy behavior was observed during the kindling process when considering the first occurrence of seizure behaviors. We defined the first occurrence of restlessness, motionless, hind limb tonic extension and Straub's tail behaviors as an early phase, myoclonic jerk as a borderline phase and tonic-clonic as a late phase of PTZ-induced kindling. Our results indicated an enhanced SVZ neurogenesis at the late phase of kindling.
Identifiants
pubmed: 34466519
doi: 10.22086/gmj.v8i0.1511
pmc: PMC8343660
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e1511Informations de copyright
Copyright© 2019, Galen Medical Journal.
Références
Epilepsy Curr. 2010 Jan;10(1):15-20
pubmed: 20126334
Molecules. 2011 Dec 06;16(12):10146-56
pubmed: 22146375
Pediatr Res. 2018 Jan;83(1-2):385-396
pubmed: 29028220
Brain Res Bull. 2016 Mar;121:138-47
pubmed: 26820711
Electroencephalogr Clin Neurophysiol. 1972 Mar;32(3):281-94
pubmed: 4110397
Curr Neurol Neurosci Rep. 2016 Feb;16(2):20
pubmed: 26769029
Comp Med. 2004 Oct;54(5):473-85
pubmed: 15575361
Cold Spring Harb Perspect Med. 2015 Jun 01;5(6):
pubmed: 26033084
Neuron. 2004 May 27;42(4):535-52
pubmed: 15157417
Neurochem Res. 2017 Jul;42(7):1873-1888
pubmed: 28290134
Cell. 2002 Aug 23;110(4):399-402
pubmed: 12202029
Clin Psychopharmacol Neurosci. 2013 Aug;11(2):45-52
pubmed: 24023547
Neuroscience. 2006 Jun 30;140(2):673-84
pubmed: 16616429
Curr Protoc Neurosci. 2012;Chapter 9:Unit9.37
pubmed: 23042503
Physiol Behav. 2009 Dec 7;98(5):579-86
pubmed: 19772866
Epilepsy Res Treat. 2012;2012:630853
pubmed: 22957234
Exp Neurol. 1969 Nov;25(3):295-330
pubmed: 4981856
J Neurochem. 2000 Feb;74(2):792-8
pubmed: 10646532
J Neurosci Methods. 2016 Feb 15;260:45-52
pubmed: 25769270
Brain Res. 2003 Apr 4;968(1):162-6
pubmed: 12644274
Exp Neurol. 1986 Sep;93(3):546-56
pubmed: 3743700
Pharmacol Rep. 2011;63(6):1316-23
pubmed: 22358080
Epilepsy Behav. 2011 Nov;22(3):433-41
pubmed: 21907628
Seizure. 2017 Jul;49:46-53
pubmed: 28242175